ACCESSWIRE

The Gross Law Firm

Share

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of WISH, FREQ and RLX

NEW YORK, NY / ACCESSWIRE / July 15, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Contextlogic Inc. (NASDAQ:WISH)

This lawsuit is on behalf of: i) all persons or entities who purchased or otherwise acquired securities of ContextLogic, Inc. ("ContextLogic") (NASDAQ: WISH) and/or sold put options of ContextLogic during the period from December 16, 2020 to May 12, 2021, inclusive; and/or (ii) all persons who purchased ContextLogic securities pursuant and/or traceable to the Company's initial public offering conducted on or about December 16, 2020.

A class action has commenced on behalf of certain shareholders in Contextlogic Inc. In the registration statement and prospectus used to conduct the initial public offering and throughout the class period, defendants made materially false and misleading statements about the strength of ContextLogic's business operations and financial prospects by overstating its then-present monthly active users ("MAUs") and MAU growth trends.

Shareholders may find more information at https://securitiesclasslaw.com/securities/contextlogic-inc-loss-submission-form/?id=17691&from=1

Frequency Therapeutics, Inc. (NASDAQ:FREQ)

Investors Affected: November 16, 2020 - March 22, 2021

A class action has commenced on behalf of certain shareholders in Frequency Therapeutics, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: the Company's Phase 2a trial results failed to live up to the Company's expectations as the results revealed no discernable difference between FX-322 and the placebo. In spite of the disappointing results, the Company continued to conduct the Phase 2a study while releasing positive statements in earnings calls, press releases, SEC filings, and pharmaceutical presentations about FX-322's potential. These statements materially misled the market and artificially inflated the value of Frequency's common stock.

Shareholders may find more information at https://securitiesclasslaw.com/securities/frequency-therapeutics-inc-loss-submission-form/?id=17691&from=1

RLX Technology Inc. (NYSE:RLX)

This lawsuit is on behalf of persons who purchased, or otherwise acquired, RLX American Depository Shares pursuant or traceable to the documents issued in connection with RLX's January 2021 initial public stock offering.

A class action has commenced on behalf of certain shareholders in RLX Technology Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: the Company's then-existing exposure to China's ongoing campaign to establish a national standard for e-cigarettes, which would bring them into line with ordinary cigarette regulations, and that RLX's reported financials were not nearly as robust as the offering materials projected, nor were they indicative of future results. As a result, investors purchased RLX shares at artificially inflated prices.

Shareholders may find more information at https://securitiesclasslaw.com/securities/rlx-technology-inc-loss-submission-form/?id=17691&from=1

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm



View source version on accesswire.com:
https://www.accesswire.com/655759/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-WISH-FREQ-and-RLX

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESSWIRE

DK